A Phase 1 Study of KHK4083 in Subjects With Atopic Dermatitis

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2017
The objective of this study is to evaluate the safety and tolerability of multiple intravenous (IV) infusions of KHK4083 in subjects with moderate or severe atopic dermatitis.
Epistemonikos ID: e8c252e805d4a7d10512cad94768ad8758aa4817
First added on: May 20, 2024